Daihan Pharmaceutical Co.,Ltd. (023910.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.1x

Market Cap

KRW 160.23B

MomentumView details →

1D Return

+1.49%

YTD Return

−7.18%

RSI (14)

57.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.1x

Market Cap

KRW 160.23B

RSI (14)

57.7

MomentumView details →

1D Return

+1.49%

YTD Return

−7.18%

ProfitabilityView details →

Gross Margin

29.54%

Net Margin

12.71%

EBITDA Margin

20.00%

ROE (TTM)

8.94%

ROA (TTM)

7.66%

Asset Turnover

0.61x

GrowthView details →

Revenue YoY

+4.27%

EPS YoY

−12.12%

FCF YoY

+46.37%

Revenue CAGR 3Y

+4.22%

EPS CAGR 3Y

+4.07%

EBITDA YoY

−11.78%

EarningsView details →

EPS (Actual)

KRW 1,148.46

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

6.59%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

3.97x

Quick Ratio

3.19x

Div Yield

3.30%

Div Rate

KRW 900.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

216.55B

Net Income (TTM)

27.53B

Op. CF (TTM)

37.33B

Latest newsMore news →

No recent news for 023910.KQ.

Similar companies

BNC Korea Co., Ltd.256840.KQ Daewon Pharmaceutical Co., Ltd.003220.KS Hana Pharm Co., Ltd.293480.KS JW Lifescience Corporation234080.KS FutureChem Co.,Ltd220100.KQ Dongwha Pharm.Co.,Ltd000020.KS Find similar companies →

Latest newsMore news →

No recent news for 023910.KQ.